Mirum Pharmaceuticals Inc...
(MIRM)
undefined
undefined%
At close: undefined
43.09
0.05%
After-hours Jan 06, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -163.41M | -135.66M | -83.99M | -103.27M | -52.55M | -17.35M |
| Depreciation & Amortization | 10.83M | 3.68M | 975.00K | 623.00K | 324.00K | n/a |
| Stock-Based Compensation | 35.02M | 27.01M | 23.09M | 12.55M | 6.07M | 51.00K |
| Other Working Capital | -5.05M | -4.51M | -5.18M | -3.07M | -2.94M | -12.00K |
| Other Non-Cash Items | 69.26M | 12.47M | -90.41M | 335.00K | -326.00K | 12.09M |
| Deferred Income Tax | n/a | -6.58M | 595.00K | 72.00K | n/a | n/a |
| Change in Working Capital | -22.64M | -21.05M | 16.98M | 611.00K | 7.12M | 2.44M |
| Operating Cash Flow | -70.94M | -120.14M | -132.76M | -89.08M | -39.36M | -373.00K |
| Capital Expenditures | -20.11M | -278.00K | -19.02M | -225.00K | -281.00K | -7.50M |
| Acquisitions | -212.76M | -7.98M | -19.00M | -38.10M | 127.50M | n/a |
| Purchase of Investments | -27.33M | -132.32M | -198.03M | -74.56M | -152.00M | n/a |
| Sales Maturities Of Investments | 153.00M | 140.30M | 157.60M | 112.66M | 24.50M | n/a |
| Other Investing Acitivies | -20.00M | 7.98M | 127.00M | 38.10M | -127.50M | -11.25M |
| Investing Cash Flow | -107.20M | 7.70M | 48.55M | 37.87M | -127.78M | -7.50M |
| Debt Repayment | 305.30M | n/a | n/a | n/a | n/a | 50.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -185.39M | 1.72M | 66.55M | 49.42M | 59.98M | n/a |
| Financial Cash Flow | 336.60M | 109.09M | 73.47M | 181.29M | 127.18M | 59.84M |
| Net Cash Flow | 158.32M | -3.34M | -10.75M | 130.12M | -39.99M | 51.96M |
| Free Cash Flow | -91.05M | -120.41M | -151.78M | -89.30M | -39.64M | -7.87M |